This compound is a pharmaceutical intermediate used in the synthesis of small molecule kinase inhibitors. It serves as a building block for active pharmaceutical ingredients in oncology research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 16153-81-4
2,4-Difluoro-5-iodobenzoic acid
pharmaceutical intermediate
4-[(4-Chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt
pharmaceutical intermediate
(S)-(+)-N-(2,3-Epoxypropyl)phthalimide
pharmaceutical intermediate
4-(4-Methylaminocarbonylphenyl)piperidine
pharmaceutical intermediate
2-Amino-4-(4-methylpiperazin-1-yl) benzoic acid tertbutyl ester
pharmaceutical intermediate
1-(2,3-Dichlorophenyl)piperazine hydrochloride
pharmaceutical intermediate
N-(3-methoxyphenyl)piperazine hydrochloride
pharmaceutical intermediate
N-(3-methoxyphenyl)piperazine
pharmaceutical intermediate
4-(4-methylpiperazin-1-yl)aniline
MOZNZNKHRXRLLF-UHFFFAOYSA-N
CN1CCN(CC1)C2=CC=C(C=C2)N